Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (191-200 of 471) with videos related to

Pageof 48
Sort By:
Kidney International Reports|May 2, 2022
Kidney Transplant Outcomes of Patients With Multiple MyelomaCihan Heybeli, Andrew J Bentall, Mariam Priya Alexander, et al.
Leukemia|September 30, 2018
Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosisJithma P Abeykoon, Saurabh Zanwar, Angela Dispenzieri, et al.
Blood Cancer Journal|September 23, 2021
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM)Matthew Ho, Saurabh Zanwar, Prashant Kapoor, et al.
Blood Advances|December 5, 2024
Prognostic impact of patient-reported symptoms in multiple myelomaNadine Abdallah, Arwa Bohra, Aytaj Mammadzadeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2018
Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75M Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Cancer|May 5, 2016
Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Advances|April 5, 2018
Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2018
Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain AmyloidosisM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2009
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidneyMorie A Gertz, Nelson Leung, Martha Q Lacy, et al.
Leukemia|February 22, 2022
Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Pageof 48

Showing results (191-200 of 471) with videos related to

Sort By:
Pageof 48
Kidney International Reports|May 2, 2022
Kidney Transplant Outcomes of Patients With Multiple MyelomaCihan Heybeli, Andrew J Bentall, Mariam Priya Alexander, et al.
Leukemia|September 30, 2018
Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosisJithma P Abeykoon, Saurabh Zanwar, Angela Dispenzieri, et al.
Blood Cancer Journal|September 23, 2021
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM)Matthew Ho, Saurabh Zanwar, Prashant Kapoor, et al.
Blood Advances|December 5, 2024
Prognostic impact of patient-reported symptoms in multiple myelomaNadine Abdallah, Arwa Bohra, Aytaj Mammadzadeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2018
Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75M Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Cancer|May 5, 2016
Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Advances|April 5, 2018
Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2018
Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain AmyloidosisM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2009
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidneyMorie A Gertz, Nelson Leung, Martha Q Lacy, et al.
Leukemia|February 22, 2022
Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Pageof 48